Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Status:
Completed
Trial end date:
2014-11-18
Target enrollment:
Participant gender:
Summary
RATIONALE: Atorvastatin calcium and celecoxib may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth. Giving atorvastatin calcium together with
celecoxib may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving atorvastatin calcium together with
celecoxib works in treating patients with rising PSA levels after local therapy for prostate
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborators:
National Cancer Institute (NCI) Rutgers Cancer Institute of New Jersey